Value of albumin-globulin ratio as a predictor of all-cause mortality after non-ST elevation myocardial infarction

Angiology

Volumn 64, Issue 2, 2013, Pages 137-145

  Azab, Basem ^a,b   Bibawy, John ^a   Harris, Kassem ^a   Khoueiry, Georges ^a   Akerman, Meredith ^c   Selim, Jason ^a   Khalil, Silivia ^a   Bloom, Scott ^a   McGinn, Joseph T ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

albumin globulin ratio; mortality; non ST segment elevation myocardial infarction

Indexed keywords

ALBUMIN; GLOBIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALBUMIN GLOBULIN RATIO; ANALYTICAL PARAMETERS; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; SCREENING; SURVIVAL;

AGED; ALBUMINS; CAUSE OF DEATH; FEMALE; GLOBULINS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS;

EID: 84872580943     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319712436577     Document Type: Article

References (44)

1. McPherson Richard 19: Specific proteins"McPherson and Pincus: Henry's clinical diagnosis and management by laboratory methods, 21st Ed. 2006. pp. 262-270. 2006: 262-270.
2. Nelson JJ, Liao D, Sharrett AR, et al. Serum albumin level as a predictor of incident coronary heart disease: the atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000 ; 151 (5). 468-477
3. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998 ; 279 ((18)). 1477-1482
4. Weijenberg MP, Feskens EJ, Souverijn JH, Kromhout D. Serum albumin, coronary heart disease risk, and mortality in an elderly cohort. Epidemiology. 1997 ; 8 (1). 87-92
5. Gillum RF, Makuc DM. Serum albumin, coronary heart disease, and death. Am Heart J. 1992 ; 123 (2). 507-513
6. Corti MC, Salive ME, Guralnik JM. Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol. 1996 ; 49 (5). 519-526
7. Kuller LH, Eichner JE, Orchard TJ, Grandits GA, McCallum L, Tracy RP. The relation between serum albumin levels and risk of coronary heart disease in the multiple risk factor intervention trial. Am J Epidemiol. 1991 ; 134 (11). 1266-1277
8. Corti MC, Guralnik JM, Salive ME, Sorkin JD. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA. 1994 ; 272 (13). 1036-1042
9. Djoussé L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham offspring study. Circulation. 2002 ; 106 (23). 2919-2924
10. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet. 1989 ; 2 (8677). 1434-1436
11. Ganotakis ES, Vrentzos GE, Gazi IF, et al. Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation. In Vivo. 2007 ; 21 (4). 685-694
12. Sims FH, Gavin JB, Edgar S, Koelmeyer T. Diffusion of gamma globulin into the arterial wall identifies localized entry of lipid and cells in atherosclerosis. Coron Artery Dis. 2001 ; 12 (1). 21-30
13. Allikmets K, Parik T, Teesalu R. Fibrinogen and the albumin-globulin ratio in essential hypertension: relations to plasma renin system activity. J Hum Hypertens. 1996 ; 10 (2). 105-109
14. Tanahashi N, Gotoh F, Tomita M, et al. Enhanced erythrocyte aggregability in occlusive cerebrovascular disease. Stroke. 1989 ; 20 (9). 1202-1207
15. Beamer N, Coull BM, Sexton G, de Garmo P, Knox R, Seaman G. Fibrinogen and the albumin-globulin ratio in recurrent stroke. Stroke. 1993 ; 24 (8). 1133-1139
16. Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010 ; 106 (4). 470-476
17. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003 ; 163 (19). 2345-2353
18. Tang EW, Wong CK, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J. 2007 ; 153 (1). 29-35
19. Bhatia RS, Garg RK, Gaur SP, et al. Predictive value of routine hematological and biochemical parameters on 30-day fatality in acute stroke. Neurol India. 2004 ; 52 (2). 220-223
20. Lowe GD. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost. 2005 ; 3 (8). 1618-1627
21. Moshage HJ, Janssen JA, Franssen JH, Hafkenscheid JC, Yap SH. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest. 1987 ; 79 (6). 1635-1641
22. Kaysen GA, Rathore V, Shearer GC, Depner TA. Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int. 1995 ; 48 (2). 510-516
23. Anavekar NS, Gans DJ, Berl T, et al. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. Kidney Int. Suppl. 2004 ; 66 (92). S50 - S55
24. Lee WS, Kim TY. Relation between red blood cell distribution width and inflammatory biomarkers in rheumatoid arthritis. Arch Pathol Lab Med. 2010 ; 134 (4). 505-506
25. Semba RD, Patel KV, Ferrucci L, et al. Serum antioxidants and inflammation predict red cell distribution width in older women: the women's health and aging study I. Clin Nutr. 2010 ; 29 (5). 600-604
26. Gibson PH, Croal BL, Cuthbertson BH, et al. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J. 2007 ; 154 (5). 995-1002
27. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006 ; 97 (7). 993-996
28. Nunez J, Nunez E, Bodi V, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008 ; 101 (6). 747-752
29. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008 ; 102 (6). 653-657
30. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008 ; 117 (2). 163-168
31. Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 2009 ; 277 (1-2). 103-108
32. Poludasu S, Marmur JD, Weedon J, Khan W, Cavusoglu E. Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention. Thromb Haemost. 2009 ; 102 (3). 581-587
33. Dabbah S, Hammerman H, Markiewicz W, Aronson D. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010 ; 105 (3). 312-317
34. Walsh PN, Mills DC, White JG. Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol. 1977 ; 36 (2). 287-296
35. Mikhailidis DP, Mikhailidis AM, Dandona P. Effect of human plasma proteins on stabilisation of platelet anti-aggregatory activity of prostacyclin. Ann Clin Biochem. 1982 ; 19 (pt 4). 241-244
36. Ishikawa Y, Sasakawa S, Takase M, Osada Y. Effect of albumin immobilization by plasma polymerization on platelet reactivity. Thromb Res. 1984 ; 35 (2). 193-202
37. Rao AK, Koike K, Day HJ, Smith JB, Holmsen H. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets. Am J Clin Pathol. 1985 ; 83 (6). 687-696
38. Porcellati S, Gresele P, Stasi M, et al. Original article: albumin prevents TxB, formation from thrombin-stimulated human platelets by sequestering the liberated arachidonic acid in the extracellular space. Platelets. 1995 ; 6 (6). 381-387
39. Gresele P, Deckmyn H, Huybrechts E, Vermylen J. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. Biochem Pharmacol. 1984 ; 33 (13). 2083-2088
40. Green RA, Russo EA, Greene RT, Kabel AL. Hypoalbuminemia-related platelet hypersensitivity in two dogs with nephrotic syndrome. J Am Vet Med Assoc. 1985 ; 186 (5). 485-488
41. Sloand EM, Bern MM, Kaldany A. Effect on platelet function of hypoalbuminemia in peritoneal dialysis. Thromb Res. 1986 ; 44 (4). 419-425
42. Mikhailidis DP, Ganotakis ES. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996 ; 7 (3). 125-137
43. Bernlochner I, Steinhubl S, Braun S, et al. Association between inflammatory biomarkers and platelet aggregation in patients under chronicclopidogrel treatment. Thromb Haemost. 2010 ; 104 (6). 1193-1200
44. Peerschke EI, Yin W, Ghebrehiwet B. Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol. 2010 ; 47 (13). 2170-2175